Santaris Can't Skirt Isis Suit Over Drug Development Deals
A California federal judge on Wednesday refused to let Santaris Pharma A/S Corp. off the hook in Isis Pharmaceuticals Inc.'s infringement suit accusing its competitor of leveraging Isis' patented gapmer antisense...To view the full article, register now.
Already a subscriber? Click here to view full article